These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23138508)

  • 1. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 3. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.
    Patlewicz G; Fitzpatrick JM
    Chem Res Toxicol; 2016 Apr; 29(4):438-51. PubMed ID: 26686752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
    Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
    Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated testing strategies for toxicity employing new and existing technologies.
    Combes RD; Balls M
    Altern Lab Anim; 2011 Jul; 39(3):213-25. PubMed ID: 21777036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.
    Blaauboer BJ; Boekelheide K; Clewell HJ; Daneshian M; Dingemans MM; Goldberg AM; Heneweer M; Jaworska J; Kramer NI; Leist M; Seibert H; Testai E; Vandebriel RJ; Yager JD; Zurlo J
    ALTEX; 2012; 29(4):411-25. PubMed ID: 23138511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
    Cronin MT; Enoch SJ; Hewitt M; Madden JC
    ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of skin sensitizers using alternative methods to animal experimentation.
    Johansson H; Lindstedt M
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities.
    Stokes WS; Wind M
    ALTEX; 2010; 27(3):87-95. PubMed ID: 21113563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of reconstructed skin models in pharmaco-toxicological trials.
    Damour O; Augustin C; Black AF
    Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated testing strategies for use in the EU REACH system.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice.
    Jaworska J; Dancik Y; Kern P; Gerberick F; Natsch A
    J Appl Toxicol; 2013 Nov; 33(11):1353-64. PubMed ID: 23670904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.